NOTE: This post has been re-upped because it seems a whole new group of stuck-at-home investors have heard the siren song of this Coronacrapper.
Never one to let an overblown media frenzy over a pandemic scare to go to waste, long-running biocon Nanoviricides (NNVC) is back.
Read the backstory from 2014 on this scam, here, in a great piece by Duff McDonald in the New York Observer. Check out some of our notes here and here, and an amazing expose of NNVC and CTIX/IPIX‘s Krishna Menon here.
Almost 6 years later this abomination has returned, capitalizing on a new viral scare and a new crop of naive suckers.
In almost 15 years of existence the company has never even begun human testing of a single drug. Not one.
But they have made extraordinary claims. None of which has ever amounted to anything except stock sales to suckers.
A brief history of this monumental piece of trash.
2005 – The company backs into a shell (Edot.com) and begins trading.
2005 – The company makes outlandish claims about developing a drug for Bird Flu.
2006, Nanovirascam didn’t just tackle that Avian flu, they made wild claims about being a LEADING treatment!
Fresh off defeating avian flu they moved on to Dengue Fever in 2007:
Oooh, we start 2008 with an Ebola scare, and NNVC is there:
Uh oh, Ebola hype dying down? No new pandemic in the news? No problem, go back to an oldie-but-goodie, AIDS:
A year later, Swine Flu:
After a few quiet years, in 2013 more AIDS!
In 2014, wow, a coronavirus scare, MERS, appears, and once again NNVC is at the ready:
Did you say moar Ebola plz? In 2015 Nanovirascam had your back:
The results of all of these “programs” to date? Not a single drug tested in humans, let alone submitted for approval, let alone approved.
Fast forward to 2020:
All the company really works on are press releases and selling worthless certs to idiot investors. Why does anyone think this time will be any different?
THE CONTENT CONTAINED IN THIS BLOG REPRESENTS ONLY THE OPINIONS OF THE AUTHOR. THE AUTHOR MAY HOLD EITHER LONG OR SHORT POSITIONS IN SECURITIES OF VARIOUS COMPANIES DISCUSSED IN THE BLOG. THIS COMMENTARY IN NO WAY CONSTITUTES INVESTMENT ADVICE, AND SHOULD NEVER BE RELIED ON IN MAKING AN INVESTMENT DECISION, EVER. THIS BLOG IS NOT A SOLICITATION OF BUSINESS: ALL INQUIRIES WILL BE IGNORED. THE CONTENT HEREIN IS INTENDED SOLELY FOR THE ENTERTAINMENT OF THE READER, AND THE AUTHOR.